Yayın: Is there any difference in ra patients for methotrexate use vs. leflunomide use as a concomitant treatment with biological and targeted synthetic dmards in turkbio registry?
| dc.contributor.author | İnanç, Nevsun | |
| dc.contributor.author | Özen, Gülşen | |
| dc.contributor.author | Yalçınkaya, Yasemin | |
| dc.contributor.author | Koca, Süleyman Serdar | |
| dc.contributor.author | Can, Gerçek | |
| dc.contributor.author | Karataş, Ahmet | |
| dc.contributor.author | Yazıcı, Ayten | |
| dc.contributor.author | Cefle, Ayşe | |
| dc.contributor.author | Tufan, Abdurrahman | |
| dc.contributor.author | Akar, Servet | |
| dc.contributor.author | Şenel, Soner | |
| dc.contributor.author | Öz, Burak | |
| dc.contributor.author | Akkoç, Nurullah | |
| dc.contributor.author | Önen, Fatoş | |
| dc.contributor.buuauthor | Dalkılıç, Ediz | |
| dc.contributor.buuauthor | Pehlivan, Yavuz | |
| dc.contributor.department | Tıp Fakültesi | |
| dc.contributor.department | Romatoloji Ana Bilim Dalı | |
| dc.contributor.researcherid | CMF-4757-2022 | |
| dc.contributor.researcherid | AAG-8227-2021 | |
| dc.date.accessioned | 2023-08-24T07:15:06Z | |
| dc.date.available | 2023-08-24T07:15:06Z | |
| dc.date.issued | 2017-10 | |
| dc.identifier.citation | İnanç, N. vd. (2017). ''Is there any difference in ra patients for methotrexate use vs. leflunomide use as a concomitant treatment with biological and targeted synthetic dmards in turkbio registry?''. Arthritis & Rheumatology, 69(Supplement 10). | |
| dc.identifier.isbn | 2326-5205 | |
| dc.identifier.issn | 2326-5191 | |
| dc.identifier.issue | Supplement 10 | |
| dc.identifier.uri | https://acrjournals.onlinelibrary.wiley.com/loi/23265205 | |
| dc.identifier.uri | http://hdl.handle.net/11452/33609 | |
| dc.identifier.volume | 69 | |
| dc.identifier.wos | 000411824100541 | |
| dc.indexed.wos | SCIE | |
| dc.language.iso | en | |
| dc.publisher | Wiley | |
| dc.relation.collaboration | Yurt içi | |
| dc.relation.journal | Arthritis & Rheumatology | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Rheumatology | |
| dc.subject.wos | Rheumatology | |
| dc.title | Is there any difference in ra patients for methotrexate use vs. leflunomide use as a concomitant treatment with biological and targeted synthetic dmards in turkbio registry? | |
| dc.type | Other | |
| dc.type.subtype | Meeting Abstract | |
| dc.wos.quartile | Q1 | |
| dspace.entity.type | Publication | |
| local.contributor.department | Tıp Fakültesi/Romatoloji Ana Bilim Dalı | |
| local.indexed.at | WOS |
Dosyalar
Lisanslı seri
1 - 1 / 1
